Atlas Trials

APOLLO(Aromatase Inhibitor Patient cOmpLiance Program With qoL Questionaire)

Clinical trial NCT00523315 · COMPLETED

Trial details

NCT number
NCT00523315
Sponsor
AstraZeneca
Status
COMPLETED
Study type
OBSERVATIONAL
Breast Cancer
Start date
2007-05-01
Primary completion
2011-04-01
Enrollment
862

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.